Vanguard Capital Wealth Advisors Bristol Myers Squibb CO Transaction History

Vanguard Capital Wealth Advisors

$78.9 Million
Q1 2025

A detailed history of Vanguard Capital Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vanguard Capital Wealth Advisors holds 4,925 shares of BMY stock, worth $235,907. This represents 0.38% of its overall portfolio holdings.

Number of Shares

4,925

Previous 6,725 26.77%

Holding current value

$235,907

Previous $380,000 21.05%

% of portfolio

0.38%

Previous 0.42%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 11, 2025	SELL	$53.9 - $63.11 $97,020 - $113,598	-1,800 Reduced 26.77%	4,925 $300,000
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $6,490 - $7,492	125 Added 1.89%	6,725 $380,000
Q3 2024 Oct 25, 2024	SELL	$39.66 - $51.75 $35,694 - $46,575	-900 Reduced 12.0%	6,600 $341,000
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $12,075 - $15,897	-300 Reduced 3.85%	7,500 $311,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $23,990 - $27,200	-500 Reduced 6.02%	7,800 $422,000
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $208,464 - $248,755	4,300 Added 107.5%	8,300 $425,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $76,452 - $84,888	-1,200 Reduced 23.08%	4,000 $255,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $111,706 - $126,701	1,700 Added 48.57%	5,200 $360,000
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $239,680 - $283,815	3,500 New	3,500 $0
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $428,458 - $471,882	-5,900 Reduced 68.6%	2,700 $207,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $67,628 - $81,092	-1,100 Reduced 11.34%	8,600 $628,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $18,770 - $21,882	350 Added 3.74%	9,700 $604,000
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $122,422 - $143,402	2,069 Added 28.42%	9,350 $553,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $85,064 - $92,635	-1,374 Reduced 15.88%	7,281 $486,000
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $307,440 - $345,779	5,181 Added 149.14%	8,655 $546,000
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $159,766 - $181,044	-2,767 Reduced 44.34%	3,474 $215,000
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $514,376 - $601,356	-9,383 Reduced 60.06%	6,241 $367,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $21,947 - $28,628	446 Added 2.94%	15,624 $1 Million
Q3 2019 Oct 18, 2019	SELL	$42.77 - $50.71 $153,159 - $181,592	-3,581 Reduced 19.09%	15,178 $769,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $41,541 - $45,935	931 Added 5.22%	18,759 $850,000
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $328,022 - $391,126	7,270 Added 68.86%	17,828 $850,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $84,842 - $110,020	-1,740 Reduced 14.15%	10,558 $548,000
Q3 2018 Oct 19, 2018	BUY	$55.19 - $62.25 $678,726 - $765,550	12,298 New	12,298 $763,000
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $266,644 - $306,961	-4,450 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $266,733 - $290,807	4,450	4,450 $0

Others Institutions Holding BMY

# of Institutions

2,784

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $102B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.

Account

Vanguard Capital Wealth Advisors Bristol Myers Squibb CO Transaction History